Drugs / Allogeneic mesenchymal stromal cells derived from adipose tissue
Allogeneic mesenchymal stromal cells derived from adipose tissue
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04466007 | Jan 2021 → May 2024 | limb ischemia | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic mesenchymal stromal cells derived from adipose tissue | “Allogeneic mesenchymal stromal cells derived from adipose tissue administered intramuscularly” NCT04466007 ↗ |
| Modality | Cell therapy | “Allogeneic mesenchymal stromal cells derived from adipose tissue” NCT04466007 ↗ |
| Route | Intramuscular | “administered intramuscularly” NCT04466007 ↗ |